Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Nov 1: Erosive GERD patients have a new treatment option after the FDA greenlit Phathom Pharmaceuticals Voquezna (vonoprazan) tabletswhich the gastrointestinal-focused company claims is the first major innovation to the U.S
New Engl J Med (2011) 365(8):770
"This is the figure that most impresses us, given it confers a level of efficacy previously unheard of and is substantially better than even Lilly's own tirzepatide," Citi analyst Geoff Meacham said, referring to the blockbuster drug Lilly sells as Mounjaro and Zepbound
This information is educational and is not medical advice
The European Medicines Agency's European Public Assessment Report (EPAR) for Wegovy does not highlight thermoregulatory concerns as a safety signal
A primary contraindication for Semaglutide / Cyanocobalamin Injection is a known hypersensitivity or allergic reaction to semaglutide, cyanocobalamin, or any of the excipients used in the formulation
